Best corrected visual acuity(BCVA) and central macular thickness (CMT) outcomes after fluocinolone acetonide intravitreal implant (FAc) injection in multitreated chronic diabetic macular edema (DME) patients. Efficacy in a real life setting in the United States

Paez Manuel; Deupree Eric William; Tolentino Michael John; Deupree Dana Madison

首页> 外文期刊>Investigative ophthalmology & visual science >Best corrected visual acuity(BCVA) and central macular thickness (CMT) outcomes after fluocinolone acetonide intravitreal implant (FAc) injection in multitreated chronic diabetic macular edema (DME) patients. Efficacy in a real life setting in the United States

【24h】

Best corrected visual acuity(BCVA) and central macular thickness (CMT) outcomes after fluocinolone acetonide intravitreal implant (FAc) injection in multitreated chronic diabetic macular edema (DME) patients. Efficacy in a real life setting in the United States

机译：最佳校正的视力（BCVA）和中央黄斑厚度（CMT）结果在氟喹啉乙烯酮含有术治疗术治疗（FAC）注射术中的多元慢性糖尿病黄斑水肿（DME）患者。在美国真实生活中的疗效

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2018年第9期|共2页
作者
Paez Manuel; Deupree Eric William; Tolentino Michael John; Deupree Dana Madison;
展开▼
作者单位

Macula Ctr Retina Miami FL USA;

Macula Ctr Retina Miami FL USA;

Macula Ctr Retina Miami FL USA;

Macula Ctr Retina Miami FL USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献

1. Best corrected visual acuity(BCVA) and central macular thickness (CMT) outcomes after fluocinolone acetonide intravitreal implant (FAc) injection in multitreated chronic diabetic macular edema (DME) patients. Efficacy in a real life setting in the United States [J] . Paez Manuel, Deupree Eric William, Tolentino Michael John, Investigative ophthalmology & visual science . 2018,第9期

机译：最佳校正的视力（BCVA）和中央黄斑厚度（CMT）结果在氟喹啉乙烯酮含有术治疗术治疗（FAC）注射术中的多元慢性糖尿病黄斑水肿（DME）患者。在美国真实生活中的疗效
2. Real-life visual and anatomical outcomes with fluocinolone acetonide (FAc) and cumulative cost of treatment in the treatment of chronic diabetic macular edema (DME) [J] . Goncalves Rita, Coelho Pedro, Teixeira Carla, Investigative ophthalmology & visual science . 2017,第8期

机译：具有氟喹啉酮丙酮酮（FAC）的现实寿命视觉和解剖结果及治疗慢性糖尿病黄斑水肿（DME）的累积治疗成本
3. Real-life visual and anatomical outcomes with fluocinolone acetonide (FAc) and cumulative cost of treatment in the treatment of chronic diabetic macular edema (DME) [J] . Goncalves Rita, Coelho Pedro, Teixeira Carla, Investigative ophthalmology & visual science . 2017,第8期

机译：具有氟喹啉酮丙酮酮（FAC）的现实寿命视觉和解剖结果及治疗慢性糖尿病黄斑水肿（DME）的累积治疗成本
4. Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME) [O] . Jessica D McCluskey, Paul L Kaufman, Kathy Wynne, 2019

机译：患有持续性或复发性糖尿病性黄斑水肿（DME）的患者早期采用fluocinolone acetonide（FAc）玻璃体内植入物
5. >Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME) [O] . Jessica D McCluskey, Paul L Kaufman, Kathy Wynne, 2019

机译：>早期采用氟尿酮酮（FAC）玻璃体植入术患者持续或复发性糖尿病黄斑水肿（DME）

Best corrected visual acuity(BCVA) and central macular thickness (CMT) outcomes after fluocinolone acetonide intravitreal implant (FAc) injection in multitreated chronic diabetic macular edema (DME) patients. Efficacy in a real life setting in the United States

著录项

相似文献

相关主题

期刊订阅